Search

everythinglearnresearchcommunity

for

Search:↓

Mesenchymal stem cells may help treat hair loss by improving hair cell growth and reducing inflammation.

Blocking interferon-gamma might help treat various autoimmune diseases.

Enz_MoriL from mulberry leaves helps hair growth by affecting specific cell pathways.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Interferon gamma alone can't cause alopecia areata in C3H/HeJ mice.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Trichloroethylene causes skin inflammation in mice by increasing certain immune proteins.

Somatostatin may help protect hair follicles from immune attacks.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

Retinol may affect immune responses in people with frequent skin boils.

Hair cortisol levels peak in the third trimester and decline postpartum.

Hair follicle stem cells can help treat ulcerative colitis in mice by releasing beneficial exosomes.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

Type I interferons play a key role in the development of various skin diseases.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

A new mouse model for vitiligo helps study immune responses and potential treatments.